{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:37:34Z","timestamp":1787744254240,"version":"build-2784847793"},"reference-count":51,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100019004","name":"deanship of research, Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["20190436"],"award-info":[{"award-number":["20190436"]}],"id":[{"id":"10.13039\/501100019004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PNT"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>In this work, CS NPs were prepared by the ionic gelation method and encapsulated\nwith MTX to treat psoriasis dermally.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>A major drawback of using MTX to treat psoriasis is its limited diffusion through the\nskin, which may cause insufficient penetration of MTX into the basal layer of the epidermis, where psoriatic\ncells are generated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Nanoparticles have been used to enhance MTX diffusion through the skin. The system prepared\nin this work is expected to direct the drug to psoriasis cells by enhancing the drug diffusion\nthrough the skin, which will increase the amount of the drug reaching the epidermis. This is expected to\nenhance the effectiveness of the drug and to decrease its systemic side effects.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Five formulations of Chitosan nanoparticles were prepared and loaded with Methotrexate using\nthe ionic gelation technique. Particle size, dispersity, charge, loading capacity and encapsulation efficacy\nwere measured. Characterization of prepared nanoparticles was conducted to confirm the formation\nof CS-NPs, successful encapsulation of MTX and its compatibility with other formulation components.\nIn vitro drug release from CS-NPs, its permeation and accumulation in rats\u2019 skin were explored.\nFinally, the anti-psoriatic activity was assessed using the \u201cmouse tail model.\u201d<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results showed that the sizes ranged from 132.13 \u00b1 0.70 to 300.60 \u00b1 4.81 nm, where SEM\ndemonstrated the spherical and uniform distribution of the NPs. The surface charge of all NPs was highly\npositive and ranged from 20.22 \u00b1 1.10 to 30.90 \u00b1 0.70 mV. Further, the EE% and LC% of the nanoparticles\nwere in the range of 77.72%-92.70% and 17.90%-21.81%, respectively. in vitro, the release of\nmethotrexate from the nanoparticles was sustained. Additionally, both the permeation and retention of\ndrugs within the skin were enhanced significantly using this system. Eventually, orthokeratosis% and\ndrug activity% showed significant superiority of MTX-CS NPs over the free drug in treating psoriasis in\nmodel mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In conclusion, MTX-CS NPs can be used to enhance the treatment of psoriasis topically.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2211738511666230502154110","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:25:12Z","timestamp":1683095112000},"page":"460-474","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Novel Chitosan Nanoparticles Loaded with Methotrexate for Topical\nTreatment of Psoriasis"],"prefix":"10.2174","volume":"11","author":[{"given":"Nusaiba K.","family":"Al-Nemrawi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, P.O.\nBox 3030, Irbid, 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej S.","family":"Khafajah","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, P.O.\nBox 3030, Irbid, 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karem H.","family":"Alzoubi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science\nand Technology, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.clindermatol.2009.06.005","volume":"28","author":"Nasir A.","year":"2010","unstructured":"Nasir A.; Nanotechnology and dermatology: Part I\u2014potential of nanotechnology. Clin Dermatol 2010,28(4),458-466","journal-title":"Clin Dermatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","volume":"58","author":"Kimball A.B.","year":"2008","unstructured":"Kimball A.B.; Gladman D.; Gelfand J.M.; National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008,58(6),1031-1042","journal-title":"J Am Acad Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jaad.2008.06.041","volume":"60","author":"Kalb R.E.","year":"2009","unstructured":"Kalb R.E.; Bagel J.; Korman N.J.; Treatment of intertriginous psoriasis: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2009,60(1),120-124","journal-title":"J Am Acad Dermatol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"152840","DOI":"10.1016\/j.tox.2021.152840","volume":"458","author":"Ezhilarasan D.","year":"2021","unstructured":"Ezhilarasan D.; Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms. Toxicology 2021,458,152840","journal-title":"Toxicology"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1208\/s12249-021-02057-z","volume":"22","author":"Biswasroy P.","year":"2021","unstructured":"Biswasroy P.; Pradhan D.; Kar B.; Ghosh G.; Rath G.; Recent advancement in topical nanocarriers for the treatment of psoriasis. AAPS PharmSciTech 2021,22(5),164","journal-title":"AAPS PharmSciTech"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/pharmaceutics13010111","volume":"13","author":"Giri B.R.","year":"2021","unstructured":"Giri B.R.; Kim J.S.; Park J.H.; Improved bioavailability and high photostability of methotrexate by spray-dried surface-attached solid dispersion with an aqueous medium. Pharmaceutics 2021,13(1),111","journal-title":"Pharmaceutics"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"102663","DOI":"10.1016\/j.jddst.2021.102663","volume":"64","author":"Khan A.","year":"2021","unstructured":"Khan A.; Qadir A.; Ali F.; Aqil M.; Phytoconstituents based nanomedicines for the management of psoriasis. J Drug Deliv Sci Technol 2021,64,102663","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.colsurfb.2016.01.021","volume":"141","author":"Bessar H.","year":"2016","unstructured":"Bessar H.; Venditti I.; Benassi L.; Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis. Colloids Surf B Biointerfac 2016,141,141-147","journal-title":"Colloids Surf B Biointerfac"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ijpharm.2014.10.067","volume":"477","author":"Pinto M.F.","year":"2014","unstructured":"Pinto M.F.; Moura C.C.; Nunes C.; Segundo M.A.; Costa Lima S.A.; Reis S.; A new topical formulation for psoriasis: Development of methotrexate-loaded nanostructured lipid carriers. Int J Pharm 2014,477(1-2),519-526","journal-title":"Int J Pharm"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jconrel.2004.08.010","volume":"100","author":"Agnihotri S.A.","year":"2004","unstructured":"Agnihotri S.A.; Mallikarjuna N.N.; Aminabhavi T.M.; Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004,100(1),5-28","journal-title":"J Control Release"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.colsurfb.2011.09.042","volume":"90","author":"Fan W.","year":"2012","unstructured":"Fan W.; Yan W.; Xu Z.; Ni H.; Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerfaces 2012,90,21-27","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1023\/A:1016418523014","volume":"19","author":"Dyer A.M.","year":"2002","unstructured":"Dyer A.M.; Hinchcliffe M.; Watts P.; Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm Res 2002,19(7),998-1008","journal-title":"Pharm Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/app.26038","volume":"105","author":"Sun Y.","year":"2007","unstructured":"Sun Y.; Wan A.; Preparation of nanoparticles composed of chitosan and its derivatives as delivery systems for macromolecules. J Appl Polym Sci 2007,105(2),552-561","journal-title":"J Appl Polym Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.carbpol.2017.07.058","volume":"175","author":"Wu J.","year":"2017","unstructured":"Wu J.; Wang Y.; Yang H.; Liu X.; Lu Z.; Preparation and biological activity studies of resveratrol loaded ionically cross-linked chitosan-TPP nanoparticles. Carbohydr Polym 2017,175,170-177","journal-title":"Carbohydr Polym"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.carbpol.2018.04.087","volume":"195","author":"Guo X.","year":"2018","unstructured":"Guo X.; Zhuang Q.; Ji T.; Multi-functionalized chitosan nanoparticles for enhanced chemotherapy in lung cancer. Carbohydr Polym 2018,195,311-320","journal-title":"Carbohydr Polym"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/ph15020149","volume":"15","author":"Al-Nemrawi N.","year":"2022","unstructured":"Al-Nemrawi N.; Hameedat F.; Al-Husein B.; Nimrawi S.; Photolytic controlled release formulation of methotrexate loaded in chitosan\/TiO2 nanoparticles for breast cancer. Pharmaceuticals (Basel) 2022,15(2),149","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.xphs.2021.10.034","volume":"111","author":"Al-Nemrawi N.K.","year":"2022","unstructured":"Al-Nemrawi N.K.; Altawabeyeh R.M.; Darweesh R.S.; Preparation and characterization of docetaxel-PLGA nanoparticles coated with folic acid-chitosan conjugate for cancer treatment. J Pharm Sci 2022,111(2),485-494","journal-title":"J Pharm Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"118819","DOI":"10.1016\/j.carbpol.2021.118819","volume":"277","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Fu S.; Lu Y.; Chitosan\/hyaluronan nanogels co-delivering methotrexate and 5-aminolevulinic acid: A combined chemo-photodynamic therapy for psoriasis. Carbohydr Polym 2022,277,118819","journal-title":"Carbohydr Polym"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ijbiomac.2018.12.014","volume":"124","author":"Barbosa A.I.","year":"2019","unstructured":"Barbosa A.I.; Costa Lima S.A.; Reis S.; Development of methotrexate loaded fucoidan\/chitosan nanoparticles with anti-inflammatory potential and enhanced skin permeation. Int J Biol Macromol 2019,124,1115-1122","journal-title":"Int J Biol Macromol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.3390\/nano11123433","volume":"11","author":"Asad M.I.","year":"2021","unstructured":"Asad M.I.; Khan D.; Rehman A.; Elaissari A.; Ahmed N.; Development and in vitro\/in vivo evaluation of pH-sensitive polymeric nanoparticles loaded hydrogel for the management of psoriasis. Nanomaterials (Basel) 2021,11(12),3433","journal-title":"Nanomaterials (Basel)"},{"key":"ref=21","first-page":"25","volume":"8","author":"Mohammadi-Samani S.","year":"2013","unstructured":"Mohammadi-Samani S.; Miri R.; Salmanpour M.; Khalighian N.; Sotoudeh S.; Erfani N.; Preparation and assessment of chitosan-coated superparamagnetic Fe3O4 nanoparticles for controlled delivery of methotrexate. Res Pharm Sci 2013,8(1),25-33","journal-title":"Res Pharm Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/10837450.2019.1619183","volume":"24","author":"Al-Nemrawi N.K.","year":"2019","unstructured":"Al-Nemrawi N.K.; Alsharif S.S.M.; Alzoubi K.H.; Alkhatib R.Q.; Preparation and characterization of insulin chitosan-nanoparticles loaded in buccal films. Pharm Dev Technol 2019,24(8),967-974","journal-title":"Pharm Dev Technol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1080\/10826076.2015.1087409","volume":"38","author":"Garg N.K.","year":"2015","unstructured":"Garg N.K.; Sharma G.; Singh B.; Nirbhavane P.; Katare O.P.; Quality by design (QbD)-based development and optimization of a simple, robust RP-HPLC method for the estimation of methotrexate. J Liq Chromatogr Relat Technol 2015,38(17),1629-1637","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/ph11010028","volume":"11","author":"Al-Nemrawi N.K.","year":"2018","unstructured":"Al-Nemrawi N.K.; Alshraiedeh N.A.H.; Zayed A.L.; Altaani B.M.J.P.; Low molecular weight chitosan-coated PLGA nanoparticles for pulmonary delivery of tobramycin for cystic fibrosis. Pharmaceuticals 2018,11(1),28","journal-title":"Pharmaceuticals"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00755-7","volume":"19","author":"Amarachinta P.R.","year":"2021","unstructured":"Amarachinta P.R.; Sharma G.; Samed N.; Chettupalli A.K.; Alle M.; Kim J-C.; Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect. J Nanobiotechnology 2021,19(1),1-15","journal-title":"J Nanobiotechnology"},{"key":"ref=26","first-page":"1","volume":"6","author":"Gouda R.","year":"2017","unstructured":"Gouda R.; Baishya H.; Qing Z.; Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets. J Dev Drugs 2017,6(02),1-8","journal-title":"J Dev Drugs"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1473-2165.2009.00468.x","volume":"8","author":"Bhatia A.","year":"2009","unstructured":"Bhatia A.; Raza K.; Singh B.; Katare O.P.; Phospholipid-based formulation with improved attributes of coal tar. J Cosmet Dermatol 2009,8(4),282-288","journal-title":"J Cosmet Dermatol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/10837450.2013.763260","volume":"19","author":"Bhatia A.","year":"2014","unstructured":"Bhatia A.; Singh B.; Wadhwa S.; Raza K.; Katare O.P.; Novel phospholipid-based topical formulations of tamoxifen: Evaluation for antipsoriatic activity using mouse-tail model. Pharm Dev Technol 2014,19(2),160-163","journal-title":"Pharm Dev Technol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2019.01.002","volume":"143","author":"Zhao Z.","year":"2019","unstructured":"Zhao Z.; Ukidve A.; Krishnan V.; Mitragotri S.; Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers. Adv Drug Deliv Rev 2019,143,3-21","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1023\/A:1023290514575","volume":"20","author":"Giannavola C.","year":"2003","unstructured":"Giannavola C.; Bucolo C.; Maltese A.; Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm Res 2003,20(4),584-590","journal-title":"Pharm Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.addr.2018.06.009","volume":"131","author":"Peltonen L.","year":"2018","unstructured":"Peltonen L.; Practical guidelines for the characterization and quality control of pure drug nanoparticles and nano-cocrystals in the pharmaceutical industry. Adv Drug Deliv Rev 2018,131,101-115","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"Danaei M.","year":"2018","unstructured":"Danaei M.; Dehghankhold M.; Ataei S.; Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 2018,10(2),57","journal-title":"Pharmaceutics"},{"key":"ref=33","first-page":"035008","volume":"7","author":"Loutfy S.A.","year":"2016","unstructured":"Loutfy S.A.; El-Din H.M.A.; Elberry M.H.; Allam N.G.; Hasanin M.; Abdellah A.M.; Synthesis, characterization and cytotoxic evaluation of chitosan nanoparticles: In vitro liver cancer model. Adv Nat Sci: Nanosci Nanotechnol 2016,7(3),035008","journal-title":"Adv Nat Sci: Nanosci Nanotechnol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.colsurfb.2005.06.001","volume":"44","author":"Gan Q.","year":"2005","unstructured":"Gan Q.; Wang T.; Cochrane C.; McCarron P.; Modulation of surface charge, particle size and morphological properties of chitosan\u2013TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 2005,44(2-3),65-73","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1016\/j.matpr.2020.01.491","volume":"33","author":"Raghavendra Naveen N.","year":"2020","unstructured":"Raghavendra Naveen N.; Kurakula M.; Gowthami B.; Process optimization by response surface methodology for preparation and evaluation of methotrexate loaded chitosan nanoparticles. Mater Today Proc 2020,33,2716-2724","journal-title":"Mater Today Proc"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1080\/21691401.2018.1562460","volume":"47","author":"Arsalani N.","year":"2019","unstructured":"Arsalani N.; Nezhad-Mokhtari P.; Jabbari E.; Microwave-assisted and one-step synthesis of PEG passivated fluorescent carbon dots from gelatin as an efficient nanocarrier for methotrexate delivery. Artif Cells Nanomed Biotechnol 2019,47(1),540-547","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"7834159","DOI":"10.1155\/2018\/7834159","volume":"2018","author":"Teja S.","year":"2018","unstructured":"Teja S.; Damodharan N.; 23 full factorial model for particle size optimization of methotrexate loaded chitosan nanocarriers: A design of experiments (DoE) Approach. BioMed Res Int 2018,2018,7834159","journal-title":"BioMed Res Int"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.2147\/IJN.S247007","volume":"15","author":"Agrawal Y.O.","year":"2020","unstructured":"Agrawal Y.O.; Mahajan U.B.; Mahajan H.S.; Ojha S.; Methotrexate-loaded nanostructured lipid carrier gel alleviates imiquimod-induced psoriasis by moderating inflammation: Formulation, optimization, characterization, in-vitro and in-vivo studies. Int J Nanomedicine 2020,15,4763-4778","journal-title":"Int J Nanomedicine"},{"key":"ref=39","author":"Silva S.M.","year":"2012","unstructured":"Silva S.M.; Braga C.R.; Fook M.V.; Raposo C.M.; Carvalho L.H.; Canedo E.L.; Application of infrared spectroscopy to analysis of chitosan\/clay nanocomposites. In: Infrared Spectroscopy 2012","journal-title":"In: Infrared Spectroscopy"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.colsurfb.2010.11.005","volume":"83","author":"Jingou J.","year":"2011","unstructured":"Jingou J.; Shilei H.; Weiqi L.; Danjun W.; Tengfei W.; Yi X.; Preparation, characterization of hydrophilic and hydrophobic drug in combine loaded chitosan\/cyclodextrin nanoparticles and in vitro release study. Colloids Surf B Biointerfaces 2011,83(1),103-107","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1208\/s12249-015-0312-2","volume":"16","author":"Obaidat R.M.","year":"2015","unstructured":"Obaidat R.M.; Tashtoush B.M.; Bayan M.F.T.; Al Bustami R.T.; Alnaief M.; Drying using supercritical fluid technology as a potential method for preparation of chitosan aerogel microparticles. AAPS PharmSciTech 2015,16(6),1235-1244","journal-title":"AAPS PharmSciTech"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10973-012-2580-3","volume":"112","author":"de Oliveira A.R.","year":"2013","unstructured":"de Oliveira A.R.; Molina E.F.; de Castro Mesquita P.; Structural and thermal properties of spray-dried methotrexate-loaded biodegradable microparticles. J Therm Anal Calorim 2013,112(2),555-565","journal-title":"J Therm Anal Calorim"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10973-011-1429-5","volume":"106","author":"Azevedo J.R.","year":"2011","unstructured":"Azevedo J.R.; Sizilio R.H.; Brito M.B.; Physical and chemical characterization insulin-loaded chitosan-TPP nanoparticles. J Therm Anal Calorim 2011,106(3),685-689","journal-title":"J Therm Anal Calorim"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s12034-014-0030-5","volume":"37","author":"Musmade K.P.","year":"2014","unstructured":"Musmade K.P.; Deshpande P.B.; Musmade P.B.; Methotrexate-loaded biodegradable nanoparticles: Preparation, characterization and evaluation of its cytotoxic potential against U-343 MGa human neuronal glioblastoma cells. Bull Mater Sci 2014,37(4),945-951","journal-title":"Bull Mater Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.carbpol.2009.02.029","volume":"77","author":"Li F.","year":"2009","unstructured":"Li F.; Wu H.; Zhang H.; Li F.; Gu C.; Yang Q.; Antitumor drug Paclitaxel-loaded pH-sensitive nanoparticles targeting tumor extracellular pH. Carbohydr Polym 2009,77(4),773-778","journal-title":"Carbohydr Polym"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3892\/etm.2019.7511","volume":"18","author":"Nedelcu R.I.","year":"2019","unstructured":"Nedelcu R.I.; Balaban M.; Turcu G.; Efficacy of methotrexate as anti inflammatory and anti proliferative drug in dermatology: Three case reports. Exp Ther Med 2019,18(2),905-910","journal-title":"Exp Ther Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.carbpol.2016.06.096","volume":"153","author":"Al-Kassas R.","year":"2016","unstructured":"Al-Kassas R.; Wen J.; Cheng A.E.M.; Kim A.M.J.; Liu S.S.M.; Yu J.; Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel. Carbohydr Polym 2016,153,176-186","journal-title":"Carbohydr Polym"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1080\/10717544.2022.2058652","volume":"29","author":"Hatem S.","year":"2022","unstructured":"Hatem S.; Elkheshen S.A.; Kamel A.O.; Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: An approach to clinically augment the therapeutic efficacy for melasma treatment. Drug Deliv 2022,29(1),1212-1231","journal-title":"Drug Deliv"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000211016","volume":"5","author":"Bosman B.","year":"1992","unstructured":"Bosman B.; Matthiesen T.; Hess V.; Friderichs E.; A quantitative method for measuring antipsoriatic activity of drugs by the mouse tail test. Skin Pharmacol Physiol 1992,5(1),41-48","journal-title":"Skin Pharmacol Physiol"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2217\/nnm.11.142","volume":"6","author":"Tan Q.","year":"2011","unstructured":"Tan Q.; Liu W.; Guo C.; Zhai G.; Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery. Int J Nanomedicine 2011,6,1621-1630","journal-title":"Int J Nanomedicine"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ijbiomac.2015.01.036","volume":"75","author":"Matos B.N.","year":"2015","unstructured":"Matos B.N.; Reis T.A.; Gratieri T.; Gelfuso G.M.; Chitosan nanoparticles for targeting and sustaining minoxidil sulphate delivery to hair follicles. Int J Biol Macromol 2015,75,225-229","journal-title":"Int J Biol Macromol"}],"container-title":["Pharmaceutical Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2211738511666230502154110","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216444\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2211738511666230502154110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:52:29Z","timestamp":1695811949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216444\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211738511666230502154110","relation":{},"ISSN":["2211-7385"],"issn-type":[{"value":"2211-7385","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-01-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}